Dysfunctional heteroreceptor complexes as novel targets for the treatment of major depressive and anxiety disorders

Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies

Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,501 · see citing works

Ghrelin is a growth-hormone-releasing acylated peptide from stomach

Kojima, M., Hosoda, H., Date, Y., Nakazato, M., Matsuo, H., & Kangawa, K. (1999) · Nature · doi:10.1038/45230 · Cited by 8,479 · see citing works

Emotion circuits in the brain

LeDoux, J. E. (2000) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.23.1.155 · Cited by 8,444 · see citing works

Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report

Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., Niederehe, G., Thase, M. E., Lavori, P. W., Lebowitz, B. D., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.11.1905 · Cited by 5,643 · see citing works

Depression

Malhi, G. S., & Mann, J. J. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31948-2 · Cited by 4,099 · see citing works

Depression, chronic diseases, and decrements in health: results from the World Health Surveys

Moussavi, S., Chatterji, S., Verdes, E., Tandon, A., Patel, V., & Ustun, B. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61415-9 · Cited by 4,070 · see citing works

Antidepressant effects of ketamine in depressed patients

Berman, R. M., Cappiello, A., Anand, A., Oren, D. A., Heninger, G. R., Charney, D. S., & Krystal, J. H. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00230-9 · Cited by 3,856 · see citing works

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.

Zarate, C. A., Singh, J. B., Carlson, P. J., Brutsche, N. E., Ameli, R., Luckenbaugh, D. A., Charney, D. S., & Manji, H. K. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.8.856 · Cited by 3,766 · see citing works

Multiple receptors for dopamine

Kebabian, J. W., & Calne, D. B. (1979) · Nature · doi:10.1038/277093a0 · Cited by 3,742 · see citing works

A Neurotrophic Model for Stress-Related Mood Disorders

Duman, R. S., & Monteggia, L. M. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.013 · Cited by 3,375 · see citing works

Subanesthetic Effects of the Noncompetitive NMDA Antagonist, Ketamine, in Humans: Psychotomimetic, Perceptual, Cognitive, and Neuroendocrine Responses

Krystal, J. H. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950030035004 · Cited by 3,330 · see citing works

A review of central 5-HT receptors and their function

Barnes, N. M., & Sharp, T. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00010-6 · Cited by 3,150 · see citing works

Twelve‐month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States

Kessler, R. C., Petukhova, M., Sampson, N. A., Zaslavsky, A. M., & Wittchen, H. (2012) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.1359 · Cited by 2,947 · see citing works

mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists

Li, N., Lee, B., Liu, R.-J., Banasr, M., Dwyer, J. M., Iwata, M., Li, X.-Y., Aghajanian, G., & Duman, R. S. (2010) · Science · doi:10.1126/science.1190287 · Cited by 2,881 · see citing works

Ghrelin: Structure and Function

Kojima, M., & Kangawa, K. (2005) · Physiological Reviews · doi:10.1152/physrev.00012.2004 · Cited by 2,810 · see citing works

Neuropeptide Y—a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide

Tatemoto, K., Carlquist, M., & Mutt, V. (1982) · Nature · doi:10.1038/296659a0 · Cited by 2,254 · see citing works

Neurotrophin-regulated signalling pathways

Reichardt, L. F. (2006) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2006.1894 · Cited by 2,195 · see citing works

Evidence-based health policy—lessons from the Global Burden of Disease Study

Murray, C. J. L., & Lopez, A. D. (1996) · Science · doi:10.1126/science.274.5288.740 · Cited by 2,178 · see citing works

Epidemiology of anxiety disorders in the 21st century

Bandelow, B., & Michaelis, S. (2015) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2015.17.3/bbandelow · Cited by 2,079 · see citing works

The mesolimbic dopamine reward circuit in depression

Nestler, E. J., & Carlezon, W. A. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.09.018 · Cited by 2,059 · see citing works

NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses

Autry, A. E., Adachi, M., Nosyreva, E., Na, E. S., Los, M. F., Cheng, P.-F., Kavalali, E. T., & Monteggia, L. M. (2011) · Nature · doi:10.1038/nature10130 · Cited by 1,926 · see citing works

Brain dopamine receptors.

Seeman, P. M. (1980) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06839-5 · Cited by 1,888 · see citing works

The Distribution and Mechanism of Action of Ghrelin in the CNS Demonstrates a Novel Hypothalamic Circuit Regulating Energy Homeostasis

Cowley, M. A., Smith, R. G., Diano, S., Tschöp, M., Pronchuk, N., Grove, K. L., Strasburger, C. J., Bidlingmaier, M., Esterman, M., Heiman, M. L., et al. (2003) · Neuron · doi:10.1016/s0896-6273(03)00063-1 · Cited by 1,679 · see citing works

Rethinking the Emotional Brain

LeDoux, J. (2012) · Neuron · doi:10.1016/j.neuron.2012.02.004 · Cited by 1,594 · see citing works

Protein detection using proximity-dependent DNA ligation assays

Fredriksson, S., Gullberg, M. T., Jarvius, J., Olsson, C., Pietras, K., Gustafsdottir, S., Östman, A., & Landegren, U. D. (2002) · Nature Biotechnology · doi:10.1038/nbt0502-473 · Cited by 1,511 · see citing works

Galanin — a novel biologically active peptide from porcine intestine

Tatemoto, K., Rökaeus, Å., Jörnvall, H., McDonald, T. J., & Mutt, V. (1983) · FEBS Letters · doi:10.1016/0014-5793(83)80033-7 · Cited by 1,490 · see citing works

Structural diversity of G protein-coupled receptors and significance for drug discovery

Lagerström, M. C., & Schiöth, H. B. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2518 · Cited by 1,489 · see citing works

Cognitive-Behavioral Therapy for Adult Anxiety Disorders: A Meta-Analysis of Randomized Placebo-Controlled Trials

Hoffman, S. G., & Smits, J. A. J. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0415 · Cited by 1,420 · see citing works

Reward, dopamine and the control of food intake: implications for obesity

Volkow, N. D., Wang, G.-J., & Baler, R. D. (2011) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2010.11.001 · Cited by 1,400 · see citing works

The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methyl-aspartate

Anis, N. A., Berry, S. C., Burton, N. R., & Lodge, D. (1983) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1983.tb11031.x · Cited by 1,399 · see citing works

Chronic stress and obesity: a new view of “comfort food”

Dallman, M. F., Pecoraro, N., Akana, S. F., la Fleur, S. E., Gomez, F., Houshyar, H., Bell, M. E., Bhatnagar, S., Laugero, K. D., & Manalo, S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1934666100 · Cited by 1,369 · see citing works

Association between obesity and psychiatric disorders in the US adult population

Simon, G. E., Von Korff, M., Saunders, K., Miglioretti, D. L., Crane, P. K., van Belle, G., & Kessler, R. C. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.7.824 · Cited by 1,338 · see citing works

The amygdala

LeDoux, J. (2007) · Current Biology · doi:10.1016/j.cub.2007.08.005 · Cited by 1,281 · see citing works

Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor

KUNISHIMA, N., Shimada, Y., Tsuji, Y., Sato, T., Yamamoto, M., Kumasaka, T., Nakanishi, S., Jingami, H., & Morikawa, K. (2000) · Nature · doi:10.1038/35039564 · Cited by 1,249 · see citing works

The role of dopamine in the pathophysiology of depression

Dunlop, B. W., & Nemeroff, C. B. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.3.327 · Cited by 1,244 · see citing works

Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial.

Murrough, J. W., Iosifescu, D. V., Chang, L. C., Al Jurdi, R. K., Green, C. E., Perez, A. M., Iqbal, S., Pillemer, S., Foulkes, A., Shah, A., et al. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.13030392 · Cited by 1,205 · see citing works

Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues.

Guan, X.-M., Yu, H., Palyha, O., McKee, K., Feighner, S., Sirinathsinghji, D., Smith, R. G., van der Ploeg, L., & Howard, A. (1997) · Brain Research. Molecular Brain Research · doi:10.1016/s0169-328x(97)00071-5 · Cited by 1,185 · see citing works

G-protein-coupled receptor heterodimerization modulates receptor function

Jordan, B. A., & Devi, L. A. (1999) · Nature · doi:10.1038/21441 · Cited by 1,169 · see citing works

Heterodimerization is required for the formation of a functional GABAB receptor

White, J. H. M., Wise, A., Main, M. J., Green, A., Fraser, N. J., Disney, G. H., Barnes, A. A., Emson, P. C., Foord, S. M., & Marshall, F. H. (1998) · Nature · doi:10.1038/25354 · Cited by 1,165 · see citing works

Social reward requires coordinated activity of nucleus accumbens oxytocin and serotonin

Dölen, G., Darvishzadeh, A., Huang, K. W., & Malenka, R. C. (2013) · Nature · doi:10.1038/nature12518 · Cited by 1,161 · see citing works

RNA therapeutics: beyond RNA interference and antisense oligonucleotides

Kole, R., Krainer, A. R., & Altman, S. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3625 · Cited by 1,152 · see citing works

Discovering Endophenotypes for Major Depression

Hasler, G., Drevets, W. C., Manji, H. K., & Charney, D. S. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300506 · Cited by 1,123 · see citing works

The subgenual anterior cingulate cortex in mood disorders

Drevets, W. C., Savitz, J., & Trimble, M. (2008) · CNS Spectrums · doi:10.1017/s1092852900013754 · Cited by 1,109 · see citing works

Cellular Mechanisms Underlying the Antidepressant Effects of Ketamine: Role of α-Amino-3-Hydroxy-5-Methylisoxazole-4-Propionic Acid Receptors

Maeng, S., Zarate, C. A., Du, J., Schloesser, R. J., McCammon, J., Chen, G., & Manji, H. K. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.05.028 · Cited by 1,103 · see citing works

Expression of ghrelin receptor mRNA in the rat and the mouse brain

Zigman, J. M., Jones, J. E., Lee, C. E., Saper, C. B., & Elmquist, J. K. (2006) · The Journal of Comparative Neurology · doi:10.1002/cne.20823 · Cited by 1,074 · see citing works

Dopamine neurons modulate neural encoding and expression of depression-related behaviour

Tye, K. M., Mirzabekov, J. J., Warden, M. R., Ferenczi, E. A., Tsai, H.-C., Finkelstein, J., Kim, S.-Y., Adhikari, A., Thompson, K. R., Andalman, A. S., et al. (2013) · Nature · doi:10.1038/nature11740 · Cited by 1,073 · see citing works

Dopamine: Functions, Signaling, and Association with Neurological Diseases

Klein, M. O., Battagello, D. S., Cardoso, A. R., Hauser, D. N., Bittencourt, J. C., & Correa, R. G. (2019) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-018-0632-3 · Cited by 1,073 · see citing works

The epidemiology of major depressive episodes: results from the International Consortium of Psychiatric Epidemiology (ICPE) Surveys

Andrade, L., Caraveo‐anduaga, J. J., Berglund, P., Bijl, R. V., Graaf, R. D., Vollebergh, W., Dragomirecka, E., Kohn, R., Keller, M., Kessler, R. C., et al. (2003) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.138 · Cited by 1,068 · see citing works

Evoked axonal oxytocin release in the central amygdala attenuates fear response

Knobloch, H. S., Charlet, A., Hoffmann, L. C., Eliava, M., Khrulev, S., Cetin, A. H., Osten, P., Schwarz, M. K., Seeburg, P. H., Stoop, R., et al. (2012) · Neuron · doi:10.1016/j.neuron.2011.11.030 · Cited by 1,049 · see citing works

The Challenge of Translation in Social Neuroscience: A Review of Oxytocin, Vasopressin, and Affiliative Behavior

Insel, T. R. (2010) · Neuron · doi:10.1016/j.neuron.2010.03.005 · Cited by 1,044 · see citing works

The oxytocin receptor: from intracellular signaling to behavior

Jurek, B., & Neumann, I. D. (2018) · Physiological Reviews · doi:10.1152/physrev.00031.2017 · Cited by 999 · see citing works

Dopamine receptor pharmacology

Seeman, P. M., & Tol, H. H. M. V. (1994) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(94)90323-9 · Cited by 969 · see citing works

Balance of brain oxytocin and vasopressin: implications for anxiety, depression, and social behaviors

Neumann, I. D., & Landgraf, R. (2012) · Trends in Neurosciences · doi:10.1016/j.tins.2012.08.004 · Cited by 954 · see citing works

Fluorescence resonance energy transfer (FRET) microscopy imaging of live cell protein localizations

Sekar, R. B., & Periasamy, A. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200210140 · Cited by 932 · see citing works

The role of the hippocampus in the pathophysiology of major depression

Campbell, S., & MacQUEEN, G. M. (2004) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0441 · Cited by 879 · see citing works

Amygdala inhibitory circuits and the control of fear memory

Ehrlich, I., Humeau, Y., Grenier, F., Ciocchi, S., Herry, C., & Lüthi, A. (2009) · Neuron · doi:10.1016/j.neuron.2009.05.026 · Cited by 878 · see citing works

Nucleus Accumbens Deep Brain Stimulation Decreases Ratings of Depression and Anxiety in Treatment-Resistant Depression

Bewernick, B. H., Hurlemann, R., Matusch, A., Kayser, S., Grubert, C., Hadrysiewicz, B., Axmacher, N., Lemke, M., Cooper-Mahkorn, D., Cohen, M. X., et al. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.013 · Cited by 865 · see citing works

Activation of the TrkB neurotrophin receptor is induced by antidepressant drugs and is required for antidepressant-induced behavioral effects

Saarelainen, T., Hendolin, P., Lucas, G., Koponen, E., Sairanen, M., MacDonald, E., Agerman, K., Haapasalo, A., Nawa, H., Aloyz, R., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-01-00349.2003 · Cited by 800 · see citing works

Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins

Lefkowitz, R. J., Cotecchia, S., Samama, P., & Costa, T. (1993) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(93)90048-o · Cited by 792 · see citing works

Recent Advances in the Molecular Biology of Dopamine Receptors

Gingrich, J. A., & Caron, M. G. (1993) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.16.030193.001503 · Cited by 785 · see citing works

G Protein-Coupled Inwardly Rectifying K+ Channels (GIRKs) Mediate Postsynaptic but Not Presynaptic Transmitter Actions in Hippocampal Neurons

Lüscher, C., Jan, L. Y., Stoffel, M., Malenka, R. C., & Nicoll, R. A. (1997) · Neuron · doi:10.1016/s0896-6273(00)80381-5 · Cited by 762 · see citing works

Dopamine system dysregulation in major depressive disorders

Belujon, P., & Grace, A. A. (2017) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyx056 · Cited by 754 · see citing works

The association between obesity and anxiety disorders in the population: a systematic review and meta-analysis

Gariepy, G., Nitka, D., & Schmitz, N. (2010) · International Journal of Obesity · doi:10.1038/ijo.2009.252 · Cited by 753 · see citing works

Biased signalling: from simple switches to allosteric microprocessors

Smith, J. S., Lefkowitz, R. J., & Rajagopal, S. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.229 · Cited by 746 · see citing works

Mechanisms of signalling and biased agonism in G protein-coupled receptors

Wootten, D. L., Christopoulos, A., Martí-Solano, M., Babu, M. M., & Sexton, P. M. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0049-3 · Cited by 730 · see citing works

THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: G protein‐coupled receptors

Alexander, S. P. H., Christopoulos, A., Davenport, A. P., Kelly, E., Mathie, A. A., Peters, J. A., Veale, E. L., Armstrong, J. F., Faccenda, E., Harding, S. D., et al. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14748 · Cited by 704 · see citing works

Increased anxiety of mice lacking the serotonin 1A receptor

Parks, C. L., Robinson, P. S., Sibille, E. L., Shenk, T. E., & Tóth, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.18.10734 · Cited by 691 · see citing works

Untitled work

(2000) · PubMed · Cited by 685 · see citing works

Roles of G‐protein‐coupled receptor dimerization

Terrillon, S., & Bouvier, M. (2004) · EMBO Reports · doi:10.1038/sj.embor.7400052 · Cited by 684 · see citing works

Mice deficient for δ- and μ-opioid receptors exhibit opposing alterations of emotional responses

Filliol, D., Ghozland, S., Chluba, J., Martin, M., Matthes, H. W. D., Simonin, F., Befort, K., Gavériaux-Ruff, C., Dierich, A., LeMeur, M., et al. (2000) · Nature Genetics · doi:10.1038/76061 · Cited by 672 · see citing works

Antidepressant drugs act by directly binding to TRKB neurotrophin receptors

Casarotto, P. C., Girych, M., Fred, S. M., Kovaleva, V., Moliner, R., Enkavi, G., Biojone, C., Cannarozzo, C., Sahu, M. P., Kaurinkoski, K., et al. (2021) · Cell · doi:10.1016/j.cell.2021.01.034 · Cited by 663 · see citing works

Immunohistochemical mapping of galanin-like neurons in the rat central nervous system

Skofitsch, G., & Jacobowitz, D. M. (1985) · Peptides · doi:10.1016/0196-9781(85)90118-4 · Cited by 659 · see citing works

Are Mood Disorders and Obesity Related? A Review for the Mental Health Professional

McElroy, S. L., Kotwal, R., Malhotra, S., Nelson, E. B., Keck, P. E., & Nemeroff, C. B. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0507 · Cited by 654 · see citing works

Anxiety disorders

Craske, M. G., Stein, M. B., Eley, T. C., Milad, M. R., Holmes, A., Rapee, R. M., & Wittchen, H.-U. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.24 · Cited by 652 · see citing works

The orexigenic hormone ghrelin defends against depressive symptoms of chronic stress

Lutter, M., Sakata, I., Osborne-Lawrence, S., Rovinsky, S. A., Anderson, J. G., Jung, S., Birnbaum, S., Yanagisawa, M., Elmquist, J. K., Nestler, E. J., et al. (2008) · Nature Neuroscience · doi:10.1038/nn.2139 · Cited by 644 · see citing works

Anxiety

Craske, M. G., & Stein, M. B. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30381-6 · Cited by 640 · see citing works

Detection of β 2 -adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET)

Angers, S., Salahpour, A., Joly, E., Hilairet, S., Chelsky, D., Dennis, M., & Bouvier, M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3684 · Cited by 639 · see citing works

The many paths to fear

Gross, C. T., & Canteras, N. S. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3301 · Cited by 596 · see citing works

G-Protein-coupled receptor oligomerization and its potential for drug discovery

George, S. R., O’Dowd, B. F., & Lee, S. P. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd913 · Cited by 590 · see citing works

Dimerization: An Emerging Concept for G Protein–Coupled Receptor Ontogeny and Function

Angers, S., Salahpour, A., & Bouvier, M. (2002) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.42.091701.082314 · Cited by 587 · see citing works

Oligomerization of μ- and δ-Opioid Receptors

George, S. R., Fan, T., Xie, Z., Tse, R., Tam, V. C., Varghese, G. K., & O’Dowd, B. F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000345200 · Cited by 557 · see citing works

Efficacy of treatments for anxiety disorders: a meta-analysis

Bandelow, B., Reitt, M., Röver, C., Michaelis, S., Görlich, Y., & Wedekind, D. (2015) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000078 · Cited by 555 · see citing works

Multiple evidence strands suggest that there may be as few as 19 000 human protein-coding genes

Ezkurdia, I., Juan, D., Rodrı́guez, J. M., Frankish, A., Diekhans, M., Harrow, J., Vázquez, J., Valencia, A., & Tress, M. L. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu309 · Cited by 551 · see citing works

Coexistence of galanin-like immunoreactivity with catecholamines, 5- hydroxytryptamine, GABA and neuropeptides in the rat CNS

Melander, T., Hökfelt, T. G. M., Rökaeus, Å., Cuello, A. C., Oertel, W., Verhofstad, A. A. J., & Goldstein, M. (1986) · Journal of Neuroscience · doi:10.1523/jneurosci.06-12-03640.1986 · Cited by 518 · see citing works

The social consequences of psychiatric disorders, III: probability of marital stability

Kessler, R. C., Walters, E. E., & Forthofer, M. S. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.8.1092 · Cited by 518 · see citing works

High constitutive signaling of the ghrelin receptor–identification of a potent inverse agonist

Holst, B., Cygankiewicz, A., Jensen, T. H., Ankersen, M., & Schwartz, T. W. (2003) · Molecular Endocrinology · doi:10.1210/me.2003-0069 · Cited by 515 · see citing works

Mesolimbic dopaminergic pathways in fear conditioning

Pezze, M. A., & Feldon, J. (2004) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2004.09.004 · Cited by 510 · see citing works

Neuromodulation by Oxytocin and Vasopressin

Stoop, R. (2012) · Neuron · doi:10.1016/j.neuron.2012.09.025 · Cited by 506 · see citing works

Coaggregation, Cointernalization, and Codesensitization of Adenosine A2A Receptors and Dopamine D2Receptors

Hillion, J., Canals, M., Torvinen, M., Casadó, V., Scott, R. P., Terasmaa, A., Hansson, A. C., Watson, S. J., Olah, M. E., Mallol, J., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107731200 · Cited by 499 · see citing works

Galanin receptor subtypes

Branchek, T. A., Smith, K. E., Gerald, C., & Walker, M. W. (2000) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01446-2 · Cited by 495 · see citing works

D1–D2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of G q /11 in the striatum

Rashid, A. J., So, C. H., Kong, M. M. C., Furtak, T., El-Ghundi, M., Cheng, R., O’Dowd, B. F., & George, S. R. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604049104 · Cited by 492 · see citing works

Cross-sectional Comparison of the Epidemiology of <i>DSM-5</i> Generalized Anxiety Disorder Across the Globe

Ruscio, A. M., Hallion, L. S., Lim, C. C. W., Aguilar-Gaxiola, S., Al-Hamzawi, A., Alonso, J., Andrade, L. H., Borges, G., Bromet, E. J., Bunting, B., et al. (2017) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2017.0056 · Cited by 492 · see citing works

Enhancing depression mechanisms in midbrain dopamine neurons achieves homeostatic resilience

Friedman, A. K., Walsh, J. J., Juarez, B., Ku, S. M., Chaudhury, D., Wang, J., Li, X., Dietz, D. M., Pan, N., Vialou, V. F., et al. (2014) · Science · doi:10.1126/science.1249240 · Cited by 484 · see citing works

G Protein-Coupled Receptor Dimerization: Function and Ligand Pharmacology

Milligan, G. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.000497 · Cited by 474 · see citing works

Dopamine D1 and D2 Receptor Co-activation Generates a Novel Phospholipase C-mediated Calcium Signal

Lee, S. P., So, C. H., Rashid, A. J., Varghese, G. K., Cheng, R., Lança, A. J., O’Dowd, B. F., & George, S. R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401923200 · Cited by 468 · see citing works

Nonviral delivery of synthetic siRNAs in vivo

Akhtar, S., & Benter, I. F. (2007) · Journal of Clinical Investigation · doi:10.1172/jci33494 · Cited by 464 · see citing works

NMDA receptor antagonists ketamine and PCP have direct effects on the dopamine D2 and serotonin 5-HT2 receptors—implications for models of schizophrenia

Kapur, S., & Seeman, P. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001093 · Cited by 459 · see citing works

Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus

Garcia, L. S. B., Comim, C. M., Valvassori, S. S., Réus, G. Z., Barbosa, L. M., Andreazza, A. C., Stertz, L., Fries, G. R., Gavioli, E. C., Kapczinski, F., et al. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.07.027 · Cited by 454 · see citing works

S ELECTIVITY IN N EUROTROPHIN S IGNALING : Theme and Variations

Segal, R. A. (2003) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.26.041002.131421 · Cited by 447 · see citing works

CNS region-specific oxytocin receptor expression: importance in regulation of anxiety and sex behavior

Bale, T. L., Davis, A. M., Auger, A. P., Dorsa, D. M., & McCarthy, M. M. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-07-02546.2001 · Cited by 446 · see citing works

Role of brain dopamine in food reward and reinforcement

Wise, R. A. (2006) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2006.1854 · Cited by 436 · see citing works

Adenosine A2A-Dopamine D2 Receptor-Receptor Heteromerization

Canals, M., Marcellino, D. J., Fanelli, F., Ciruela, F., de Benedetti, P., Goldberg, S. R., Neve, K. A., Fuxé, K., Agnati, L. F., Woods, A. S., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306451200 · Cited by 432 · see citing works

Direct protein–protein coupling enables cross-talk between dopamine D5 and γ-aminobutyric acid A receptors

Liu, F., Wan, Q., Pristupa, Z. B., Yu, X., Wang, Y. T., & Niznik, H. B. (2000) · Nature · doi:10.1038/35002014 · Cited by 430 · see citing works

Morphine use after combat injury in Iraq and post-traumatic stress disorder

Holbrook, T. L., Galarneau, M. R., Dye, J. L., Quinn, K., & Dougherty, A. L. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0903326 · Cited by 429 · see citing works

Cortical 5-HT 2A Receptor Signaling Modulates Anxiety-Like Behaviors in Mice

Weisstaub, N., Zhou, M., Lira, A., Lambe, E. K., González‐Maeso, J., Hornung, J., Sibille, E. L., Underwood, M. D., Itohara, S., Dauer, W. T., et al. (2006) · Science · doi:10.1126/science.1123432 · Cited by 425 · see citing works

Ketamine and Rapid-Acting Antidepressants: A Window into a New Neurobiology for Mood Disorder Therapeutics

Abdallah, C. G., Sanacora, G., Duman, R. S., & Krystal, J. H. (2015) · Annual Review of Medicine · doi:10.1146/annurev-med-053013-062946 · Cited by 422 · see citing works

Brain-derived neurotrophic factor in the ventral midbrain-nucleus accumbens pathway: a role in depression

Eisch, A. J., Bolaños, C. A., de Wit, J., Simonak, R. D., Pudiak, C. M., Barrot, M., Verhaagen, J., & Nestler, E. J. (2003) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.08.003 · Cited by 420 · see citing works

Structure and function of receptors coupled to G proteins

Baldwin, J. M. (1994) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(94)90134-1 · Cited by 388 · see citing works

The role of serotonin 5-HT2A receptors in memory and cognition

Zhang, G., & Stackman, R. W. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00225 · Cited by 386 · see citing works

A role for heterodimerization of μ and δ opiate receptors in enhancing morphine analgesia

Gomes, I., Gupta, A., Filipovska, J., Szeto, H. H., Pintar, J. E., & Devi, L. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307601101 · Cited by 386 · see citing works

Oxytocin Selectively Gates Fear Responses Through Distinct Outputs from the Central Amygdala

Viviani, D., Charlet, A., van den Burg, E., Robinet, C., Hurni, N., Abatis, M., Magara, F., & Stoop, R. (2011) · Science · doi:10.1126/science.1201043 · Cited by 381 · see citing works

Heterodimerization of G Protein-Coupled Receptors: Specificity and Functional Significance

Prinster, S. C., Hague, C., & Hall, R. A. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.3.1 · Cited by 373 · see citing works

BDNF release is required for the behavioral actions of ketamine

Lepack, A. E., Fuchikami, M., Dwyer, J. M., Banasr, M., & Duman, R. S. (2015) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyu033 · Cited by 368 · see citing works

Dopamine and depression

Brown, A. S., & Gershon, S. (1993) · Journal of Neural Transmission · doi:10.1007/bf01245227 · Cited by 359 · see citing works

Anxiolytic-Like Action of Neuropeptide Y: Mediation by Y1 Receptors in Amygdala, and Dissociation from Food Intake Effects

Heilig, M. A., McLeod, S., Brot, M. D., Heinrichs, S. C., Menzaghi, F., Koob, G. F., & Britton, K. T. (1993) · Neuropsychopharmacology · doi:10.1038/npp.1993.35 · Cited by 356 · see citing works

Major Depressive Disorder: Advances in Neuroscience Research and Translational Applications

Li, Z., Ruan, M., Chen, J., & Fang, Y. (2021) · Neuroscience Bulletin · doi:10.1007/s12264-021-00638-3 · Cited by 352 · see citing works

Role of the dopaminergic system in depression

Kapur, S., & Mann, J. J. (1992) · Biological Psychiatry · doi:10.1016/0006-3223(92)90137-o · Cited by 350 · see citing works

Involvement of AMPA receptor in both the rapid and sustained antidepressant-like effects of ketamine in animal models of depression

Koike, H., Iijima, M., & Chaki, S. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.05.035 · Cited by 346 · see citing works

GABAB receptors – the first 7TM heterodimers

Marshall, F. H., JONES, K. A., Kaupmann, K., & Bettler, B. (1999) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01383-8 · Cited by 345 · see citing works

Detection of beta 2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET)

Angers, S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.060590697 · Cited by 341 · see citing works

Allosteric communication between protomers of dopamine class A GPCR dimers modulates activation

Han, Y., Moreira, I. S., Urizar, E., Weinstein, H., & Javitch, J. A. (2009) · Nature Chemical Biology · doi:10.1038/nchembio.199 · Cited by 339 · see citing works

Oligomerization of opioid receptors with beta 2-adrenergic receptors: A role in trafficking and mitogen-activated protein kinase activation

Jordan, B. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.011384898 · Cited by 328 · see citing works

Adenosine A 2A receptor antagonist treatment of Parkinson’s disease

Bara‐Jimenez, W., Sherzai, A. Z., Dimitrova, T. D., Favit, A., Bibbiani, F., Gillespie, M., Morris, M. J., Mouradian, M. M., & Chase, T. N. (2003) · Neurology · doi:10.1212/01.wnl.0000073136.00548.d4 · Cited by 328 · see citing works

Molecular Mechanisms and Therapeutical Implications of Intramembrane Receptor/Receptor Interactions among Heptahelical Receptors with Examples from the Striatopallidal GABA Neurons

Agnati, L. F., Ferré, S., Lluı́s, C., Franco, R., & Fuxé, K. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.3.2 · Cited by 322 · see citing works

Anxiety in the eating disorders: Understanding the overlap

Pallister, E., & Waller, G. (2008) · Clinical Psychology Review · doi:10.1016/j.cpr.2007.07.001 · Cited by 315 · see citing works

Differential effects of the novel kappa opioid receptor antagonist, JDTic, on reinstatement of cocaine-seeking induced by footshock stressors vs cocaine primes and its antidepressant-like effects in rats

Beardsley, P. M., Howard, J. L., Shelton, K. L., & Carroll, F. I. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0167-4 · Cited by 312 · see citing works

Serotonin receptors involved in antidepressant effects

Artigas, F. (2013) · Pharmacology &amp; Therapeutics · doi:10.1016/j.pharmthera.2012.09.006 · Cited by 311 · see citing works

Autoradiographic distribution of 125I-galanin binding sites in the rat central nervous system

Skofitsch, G., Sills, M. A., & Jacobowitz, D. M. (1986) · Peptides · doi:10.1016/0196-9781(86)90133-6 · Cited by 302 · see citing works

Opioid-induced tolerance and dependence in mice is modulated by the distance between pharmacophores in a bivalent ligand series

Daniels, D. J., Lenard, N. R., Etienne, C. L., Law, P., Roerig, S. C., & Portoghese, P. S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506627102 · Cited by 297 · see citing works

Role of dopamine receptor mechanisms in the amygdaloid modulation of fear and anxiety: Structural and functional analysis

de la Mora, M. P., Gallegos-Cari, A., Arizmendi-García, Y., Marcellino, D., & Fuxe, K. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.10.010 · Cited by 296 · see citing works

The role of dopamine in the mechanism of action of antidepressant drugs

D’Aquila, P. S., Collu, M., Gessa, G. L., & Serra, G. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00566-5 · Cited by 290 · see citing works

Cerebrospinal Fluid Monoamine Metabolites and Suicidal Behavior in Depressed Patients

Roy, A. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810070035005 · Cited by 284 · see citing works

Detection of heteromerization of more than two proteins by sequential BRET-FRET

Carriba, P., Navarro, G., Ciruela, F., Ferré, S., Casadó, V., Agnati, L. F., Cortés, A., Mallol, J., Fuxé, K., Canela, E. I., et al. (2008) · Nature Methods · doi:10.1038/nmeth.1229 · Cited by 281 · see citing works

Ghrelin amplifies dopamine signaling by cross talk involving formation of growth hormone secretagogue receptor/dopamine receptor subtype 1 heterodimers.

Jiang, H., Betancourt, L., & Smith, R. G. (2006) · Molecular Endocrinology · doi:10.1210/me.2005-0084 · Cited by 279 · see citing works

Integrated events in central dopamine transmission as analyzed at multiple levels. Evidence for intramembrane adenosine A2A/dopamine D2 and adenosine A1/dopamine D1 receptor interactions in the basal ganglia1Published on the World Wide Web on 12 January 1998.1

Fuxé, K., Ferré, S., Zoli, M., & Agnati, L. F. (1998) · Brain Research Reviews · doi:10.1016/s0165-0173(97)00049-0 · Cited by 277 · see citing works

Calcium signaling cascade links dopamine D1–D2 receptor heteromer to striatal BDNF production and neuronal growth

Hasbi, A., Fan, T., Alijaniaram, M., Nguyen, T., Perreault, M. L., O’Dowd, B. F., & George, S. R. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903676106 · Cited by 274 · see citing works

The Role of Oxytocin in Psychiatric Disorders: A Review of Biological and Therapeutic Research Findings

Cochran, D. M., Fallon, D., Hill, M., & Frazier, J. A. (2013) · Harvard Review of Psychiatry · doi:10.1097/hrp.0b013e3182a75b7d · Cited by 267 · see citing works

Conformational cross-talk between α2A-adrenergic and μ-opioid receptors controls cell signaling

Vilardaga, J., Nikolaev, V. O., Lorenz, K., Ferrandon, S., Zhuang, Z., & Lohse, M. J. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.64 · Cited by 264 · see citing works

TrkB Receptor Signalling: Implications in Neurodegenerative, Psychiatric and Proliferative Disorders

Gupta, V., You, Y., Gupta, V. B., Klistorner, A. I., & Graham, S. L. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140510122 · Cited by 259 · see citing works

Monitoring Receptor Oligomerization Using Time-resolved Fluorescence Resonance Energy Transfer and Bioluminescence Resonance Energy Transfer

McVey, M., Ramsay, D., Kellett, E., Rees, S., Wilson, S., Pope, A. J., & Milligan, G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008902200 · Cited by 257 · see citing works

Oxytocin reduces anxiety via ERK1/2 activation: local effect within the rat hypothalamic paraventricular nucleus

Blume, A., Bosch, O. J., Miklos, S., Torner, L., Wales, L., Waldherr, M., & Neumann, I. D. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06184.x · Cited by 255 · see citing works

The role of dopamine in reward and pleasure behaviour – review of data from preclinical research

Bressan, R. A., & Crippa, J. A. S. (2005) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2005.00540.x · Cited by 254 · see citing works

Plasma brain derived neurotrophic factor (BDNF) and response to ketamine in treatment-resistant depression

Haile, C. N., Murrough, J. W., Iosifescu, D. V., Chang, L. C., Al Jurdi, R. K., Foulkes, A., Iqbal, S., Mahoney, J. J., De La Garza, R., Charney, D. S., et al. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713001119 · Cited by 253 · see citing works

Onset and Early Behavioral Effects of Pharmacologically Different Antidepressants and Placebo in Depression

Katz, M. M., Tekell, J. L., Bowden, C. L., Brannan, S., Houston, J. P., Berman, N., & Frazer, A. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300341 · Cited by 252 · see citing works

Mechanistic Target of Rapamycin–Independent Antidepressant Effects of ( R )-Ketamine in a Social Defeat Stress Model

Yang, C., Ren, Q., Qu, Y., Zhang, J., Ma, M., Dong, C., & Hashimoto, K. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.05.016 · Cited by 252 · see citing works

Detection of Antigen Interactions Ex Vivo by Proximity Ligation Assay: Endogenous Dopamine D2-Adenosine A2A Receptor Complexes in the Striatum

Trifilieff, P., Rives, M., Urizar, E., Piskorowski, R. A., Vishwasrao, H. D., Castrillon, J., Schmauss, C., Slättman, M., Gullberg, M. T., & Javitch, J. A. (2011) · BioTechniques · doi:10.2144/000113719 · Cited by 250 · see citing works

Pathophysiology of depression and innovative treatments: remodeling glutamatergic synaptic connections

Duman, R. S. (2014) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2014.16.1/rduman · Cited by 249 · see citing works

From the Golgi–Cajal mapping to the transmitter-based characterization of the neuronal networks leading to two modes of brain communication: Wiring and volume transmission

Fuxé, K., Dahlström, A. B., Höistad, M., Marcellino, D. J., Jansson, A., Rivera, A., Dı́az-Cabiale, Z., Jacobsen, K. R., Tinner, B., Hagman, B., et al. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.02.009 · Cited by 247 · see citing works

BDNF activates mTOR to regulate GluR1 expression required for memory formation

Slipczuk, L., Bekinschtein, P., Katche, C., Cammarota, M., Izquierdo, I., & Medina, J. H. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006007 · Cited by 246 · see citing works

Genomic sciences and the medicine of tomorrow

Drews, J. (1996) · Nature Biotechnology · doi:10.1038/nbt1196-1516 · Cited by 246 · see citing works

A systematic review and meta-analysis of the efficacy of intravenous ketamine infusion for treatment resistant depression: January 2009 – January 2019

Marcantoni, W. S., Akouamba, B. S., Wassef, M., Mayrand, J., Lai, H., Richard‐Devantoy, S., & Beauchamp, S. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.09.007 · Cited by 246 · see citing works

Molecular mechanisms of the rapid-acting and long-lasting antidepressant actions of (R)-ketamine

Hashimoto, K. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.113935 · Cited by 239 · see citing works

Dopamine transporter cell surface localization facilitated by a direct interaction with the dopamine D2 receptor

Lee, F., Pei, L., Moszczynska, A., Vukusic, B., Fletcher, P., & Liu, F. (2007) · EMBO Journal · doi:10.1038/sj.emboj.7601656 · Cited by 237 · see citing works

Ghrelin signalling and obesity: At the interface of stress, mood and food reward

Schellekens, H., Finger, B. C., Dinan, T. G., & Cryan, J. F. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.06.004 · Cited by 229 · see citing works

Anxiolytic-Like Effects of κ-Opioid Receptor Antagonists in Models of Unlearned and Learned Fear in Rats

Knoll, A. T., Meloni, E. G., Thomas, J. B., Carroll, F. I., & Carlezon, W. A. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.127415 · Cited by 227 · see citing works

A comparison of the effects of diazepam versus several typical and atypical anti-depressant drugs in an animal model of anxiety

Bodnoff, S. R., Suranyi-Cadotte, B., Quirion, R., & Meaney, M. J. (1989) · Psychopharmacology · doi:10.1007/bf00442264 · Cited by 221 · see citing works

Ketamine and depression: a narrative review

Corriger, A., & Pickering, G. P. (2019) · Drug Design Development and Therapy · doi:10.2147/dddt.s221437 · Cited by 219 · see citing works

The G protein-coupled receptor subset of the rat genome

Gloriam, D. E. I., Fredriksson, R., & Schiöth, H. B. (2007) · BMC Genomics · doi:10.1186/1471-2164-8-338 · Cited by 215 · see citing works

D2/D3 Dopamine Receptor Heterodimers Exhibit Unique Functional Properties

Scarselli, M., Novi, F., Schallmach, E., Lin, R., Baragli, A., Colzi, A., Griffon, N., Corsini, G. U., Sokoloff, P., Levenson, R. G., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102297200 · Cited by 214 · see citing works

Behavioral effects of neuropeptides in rodent models of depression and anxiety

Rotzinger, S., Lovejoy, D. A., & Tan, L. A. (2010) · Peptides · doi:10.1016/j.peptides.2009.12.015 · Cited by 211 · see citing works

Overweight and Obesity Affect Treatment Response in Major Depression

Kloiber, S., Ising, M., Reppermund, S., Horstmann, S., Dose, T., Majer, M., Zihl, J., Pfister, H., Unschuld, P. G., Holsboer, F., et al. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.10.001 · Cited by 208 · see citing works

The Neuropeptide Y (NPY) Y1 Receptor Subtype Mediates NPY-induced Antidepressant-like Activity in the Mouse Forced Swimming Test

Redrobe, J. P. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00403-1 · Cited by 207 · see citing works

Amygdaloid D1 dopamine receptor involvement in Pavlovian fear conditioning

Guarraci, F. A., Frohardt, R. J., & Kapp, B. S. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01291-3 · Cited by 207 · see citing works

CRF1-R Activation of the Dynorphin/Kappa Opioid System in the Mouse Basolateral Amygdala Mediates Anxiety-Like Behavior

Bruchas, M. R., Land, B. B., Lemos, J. C., & Chavkin, C. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008528 · Cited by 204 · see citing works

Homo- and hetero-oligomeric interactions between G-protein-coupled receptors in living cells monitored by two variants of bioluminescence resonance energy transfer (BRET): hetero-oligomers between receptor subtypes form more efficiently than between less closely related sequences

Ramsay, D., Kellett, E., McVey, M., Stephen, R. E. E. S., & Milligan, G. (2002) · Biochemical Journal · doi:10.1042/bj20020251 · Cited by 203 · see citing works

Galanin GAL-R1 Receptor Null Mutant Mice Display Increased Anxiety-Like Behavior Specific to the Elevated Plus-Maze

Holmes, A., Kinney, J. W., Wrenn, C. C., Li, Q., Yang, R. J., Ma, L., Vishwanath, J., Saavedra, M. C., Innerfield, C. E., Jacoby, A. S., et al. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300164 · Cited by 202 · see citing works

G Protein-coupled Receptors Form Stable Complexes with Inwardly Rectifying Potassium Channels and Adenylyl Cyclase

Lavine, N. E., Éthier, N., Oak, J. N., Pei, L., Liu, F., Trieu, P., Rebois, R. V., Bouvier, M., Hébert, T. E., & Tol, H. H. M. V. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205035200 · Cited by 201 · see citing works

Receptor–receptor interactions within receptor mosaics. Impact on neuropsychopharmacology

Fuxé, K., Marcellino, D. J., Rivera, A., Dı́az-Cabiale, Z., Filip, M., Gago, B., Roberts, D. C. S., Langel, Ü., Genedani, S., Ferraro, L., et al. (2008) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.11.007 · Cited by 199 · see citing works

The Modulatory Role of Dopamine in Anxiety-like Behavior.

Zarrindast, M., & Khakpai, F. (2015) · PubMed · Cited by 199 · see citing works

Heterodimerization of serotonin receptors 5-HT1A and 5-HT7 differentially regulates receptor signalling and trafficking

Renner, U., Zeug, A., Woehler, A., Niebert, M., Dityatev, A. E., Dityatev, A. E., Gorinski, N., Guseva, D., Galil, D. A., Fröhlich, M., et al. (2012) · Journal of Cell Science · doi:10.1242/jcs.101337 · Cited by 198 · see citing works

The effect of imipramine of central 5-hydroxytryptamine neurons

Carlsson, A., Fuxé, K., & Ungerstedt, U. (1968) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1968.tb09706.x · Cited by 196 · see citing works

Interactions between NPY and CRF in the amygdala to regulate emotionality

Sajdyk, T. J., Shekhar, A., & Gehlert, D. R. (2004) · Neuropeptides · doi:10.1016/j.npep.2004.05.006 · Cited by 183 · see citing works

FGF acts as a co-transmitter through adenosine A2A receptor to regulate synaptic plasticity

Flajolet, M., Wang, Z., Futter, M., Shen, W., Nuangchamnong, N., Bendor, J., Wallach, I., Nairn, A. C., Surmeier, D. J., & Greengard, P. (2008) · Nature Neuroscience · doi:10.1038/nn.2216 · Cited by 182 · see citing works

Anxiolytic- and antidepressant-like profiles of the galanin-3 receptor (Gal 3 ) antagonists SNAP 37889 and SNAP 398299

Swanson, C. J., Blackburn, T. P., Zhang, X., Zheng, K., Xu, Q., Hökfelt, T. G. M., Wolinsky, T. D., Konkel, M. J., Chen, H., Zhong, H., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508970102 · Cited by 182 · see citing works

Reevaluation of the indoleamine hypothesis of depression. Evidence for a reduction of functional activity of central 5-HT systems by antidepressant drugs

Ögren, S. O., Fuxé, K., Agnati, L. F., Gustafssons, J. �., JONSSON, G., & Holm, A. C. (1979) · Journal of Neural Transmission · doi:10.1007/bf01250331 · Cited by 181 · see citing works

Potential Anxiolytic and Antidepressant-Like Activities of SNC80, a Selective δ-Opioid Agonist, in Behavioral Models in Rodents

Saitoh, A., Kimura, Y., Suzuki, T., Kawai, K., Nagase, H., & Kamei, J. (2004) · Journal of Pharmacological Sciences · doi:10.1254/jphs.fpj04014x · Cited by 180 · see citing works

Evidence for the existence of dopamine d2-oxytocin receptor heteromers in the ventral and dorsal striatum with facilitatory receptor–receptor interactions

Romero-Fernandez, W., Borroto-Escuela, D. O., Agnati, L. F., & Fuxe, K. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.103 · Cited by 179 · see citing works

Biogenic Amine Metabolites in Cerebrospinal Fluid of Depressed and Manic Patients

MENDELS, J., Frazer, A., Fitzgerald, R. G., Ramsey, T., & Stokes, J. W. (1972) · Science · doi:10.1126/science.175.4028.1380 · Cited by 179 · see citing works

Uncoupling the dopamine D1-D2 receptor complex exerts antidepressant-like effects

Pei, L., Li, S., Wang, M., Diwan, M., Anisman, H., Fletcher, P. J., Nóbrega, J. N., & Liu, F. (2010) · Nature Medicine · doi:10.1038/nm.2263 · Cited by 176 · see citing works

Functional Interactions between μ Opioid and α2A-Adrenergic Receptors

Jordan, B. A., Gomes, I., Rios, C., Filipovska, J., & Devi, L. A. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.6.1317 · Cited by 173 · see citing works

Evidence for Adenosine/Dopamine Receptor Interactions Indications for Heteromerization

Franco, R. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00144-5 · Cited by 172 · see citing works

The prevalence of post-traumatic stress disorder related symptoms in Coronavirus outbreaks: A systematic-review and meta-analysis

Salehi, M., Amanat, M., Mohammadi, M.-R., Salmanian, M., Rezaei, N., Saghazadeh, A., & Garakani, A. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.12.188 · Cited by 172 · see citing works

Simultaneous targeting of multiple opioid receptors: a strategy to improve side-effect profile

Dietis, N., Guerrini, R., Calò, G., Salvadori, S., Rowbotham, D. J., & Lambert, D. G. (2009) · British Journal of Anaesthesia · doi:10.1093/bja/aep129 · Cited by 171 · see citing works

The Best of Both Worlds? Bitopic Orthosteric/Allosteric Ligands of G Protein–Coupled Receptors

Valant, C., Lane, J. R., Sexton, P. M., & Christopoulos, A. (2011) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010611-134514 · Cited by 169 · see citing works

Emerging drugs for the treatment of anxiety

Murrough, J. W., Yaqubi, S., Sayed, S., & Charney, D. S. (2015) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2015.1049996 · Cited by 168 · see citing works

Increased Ethanol Self‐Administration in δ‐Opioid Receptor Knockout Mice

Roberts, A. J., Gold, L. H., Polis, I. Y., McDonald, J. S., Filliol, D., Kieffer, B. L., & Koob, G. F. (2001) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2001.tb02344.x · Cited by 168 · see citing works

The Amygdala as a Neurobiological Target for Ghrelin in Rats: Neuroanatomical, Electrophysiological and Behavioral Evidence

Álvarez-Crespo, M., Skibicka, K. P., Farkas, I., Molnár, C. S., Egecioglu, E., Hrabovszky, E., Liposits, Z., & Dickson, S. L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046321 · Cited by 166 · see citing works

Heteromeric Dopamine Receptor Signaling Complexes: Emerging Neurobiology and Disease Relevance

Perreault, M. L., Hasbi, A., O’Dowd, B. F., & George, S. R. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.148 · Cited by 165 · see citing works

Biological markers of generalized anxiety disorder

Maron, E., & Nutt, D. (2017) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2017.19.2/dnutt · Cited by 164 · see citing works

Modulation by cholecystokinins of 3H‐spiroperidol binding in rat striatum: evidence for increased affinity and reduction in the number of binding sites

Fuxé, K., Agnati, L. F., Benfenati, F., CIMMINO, M., Algeri, S., Hökfelt, T. G. M., & Mutt, V. (1981) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1981.tb06942.x · Cited by 157 · see citing works

Promiscuous Dimerization of the Growth Hormone Secretagogue Receptor (GHS-R1a) Attenuates Ghrelin-mediated Signaling

Schellekens, H., van Oeffelen, W. E. P. A., Dinan, T. G., & Cryan, J. F. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.382473 · Cited by 153 · see citing works

Evidence for the existence of receptor--receptor interactions in the central nervous system. Studies on the regulation of monoamine receptors by neuropeptides.

Fuxé, K., Agnati, L. F., Benfenati, F., Celani, M. F., Zini, I., Zoli, M., & Mutt, V. (1983) · PubMed · Cited by 153 · see citing works

Galanin – 25 years with a multitalented neuropeptide

Mitsukawa, K., Lü, X., & Bartfai, T. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8153-8 · Cited by 151 · see citing works

Delta opioid receptor ligands modulate anxiety‐like behaviors in the rat

Perrine, S. A., Hoshaw, B. A., & Unterwald, E. M. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706686 · Cited by 144 · see citing works

Neuropeptide-Y exerts antidepressant-like effects in the forced swim test in rats

Stogner, K. A., & Holmes, P. V. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00800-6 · Cited by 144 · see citing works

Kappa Opioid Receptor Signaling in the Basolateral Amygdala Regulates Conditioned Fear and Anxiety in Rats

Knoll, A. T., Muschamp, J. W., Daws, S. E., Ferguson, D., Dietz, D., Meloni, E. G., Carroll, F. I., Nestler, E. J., Konradi, C. L., & Carlezon, W. A. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.03.017 · Cited by 141 · see citing works

The effects of intra-amygdaloid infusions of a D-sub-2 dopamine receptor antagonist on Pavlovian fear conditioning.

Guarraci, F. A., Frohardt, R. J., Falls, W. A., & Kapp, B. S. (2000) · Behavioral Neuroscience · doi:10.1037//0735-7044.114.3.647 · Cited by 140 · see citing works

Reversal of Depressed Behaviors in Mice by p11 Gene Therapy in the Nucleus Accumbens

Alexander, B., Warner-Schmidt, J., Eriksson, T. M., Tamminga, C., Arango-Lievano, M., Ghose, S., Vernov, M., Stavarache, M., Musatov, S., Flajolet, M., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001079 · Cited by 140 · see citing works

The effects of intra-amygdaloid infusions of a D₂ dopamine receptor antagonist on Pavlovian fear conditioning.

Guarraci, F. A., Frohardt, R. J., Falls, W. A., & Kapp, B. S. (2000) · Behavioral Neuroscience · doi:10.1037/0735-7044.114.3.647 · Cited by 140 · see citing works

Molecular pathways of major depressive disorder converge on the synapse

Fries, G. R., Saldana, V. A., Finnstein, J., & Rein, T. (2023) · Molecular Psychiatry · doi:10.1038/s41380-022-01806-1 · Cited by 504 · see citing works

Alleviating anxiety and taming trauma: Novel pharmacotherapeutics for anxiety disorders and posttraumatic stress disorder

Singewald, N., Sartori, S. B., Reif, A., & Holmes, A. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109418 · Cited by 61 · see citing works

The oxytocin receptor represents a key hub in the GPCR heteroreceptor network: Potential relevance for brain and behavior

Borroto-Escuela, D. O., Cuesta-Marti, C., Lopez-Salas, A., Chruścicka-Smaga, B., Crespo-Ramírez, M., Tesoro-Cruz, E., Palacios-Lagunas, D. A., Perez de la Mora, M., Schellekens, H., & Fuxe, K. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.1055344 · Cited by 38 · see citing works

Functional Dimerization of Serotonin Receptors: Role in Health and Depressive Disorders

Mitroshina, E., Marasanova, E., & Vedunova, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242216416 · Cited by 34 · see citing works

Ginsenoside Rg1: A Neuroprotective Natural Dammarane‐Type Triterpenoid Saponin With Anti‐Depressive Properties

Han, D., Zhao, Z., Mao, T., Gao, M., Yang, X., & Gao, Y. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70150 · Cited by 30 · see citing works

Membrane Heteroreceptor Complexes as Second-Order Protein Modulators: A Novel Integrative Mechanism through Allosteric Receptor–Receptor Interactions

Mirchandani‐Duque, M., Choucri, M., Hernández-Mondragón, J. C., Crespo‐Ramírez, M., Pérez-Olives, C., Ferraro, L., Franco, R., de la Mora, M. P., Fuxé, K., & Borroto‐Escuela, D. O. (2024) · Membranes · doi:10.3390/membranes14050096 · Cited by 14 · see citing works

The neurobiology of major depressive disorder: Updates and perspectives from proteomics

Spero, V., D'Amelio, S., Eligini, S., Molteni, R., Banfi, C., & Cattaneo, M. G. (2025) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2025.102855 · Cited by 6 · see citing works

Apelin Receptor Dimerization and Oligomerization

Yeganeh‐Hajahmadi, M., Moosavi-Saeed, Y., & Rostamzadeh, F. (2023) · Current Molecular Pharmacology · doi:10.2174/1874467217666230818113538 · Cited by 5 · see citing works

Galanin Receptors: G Protein-Dependent Signaling and Beyond

Oláh, J., Soltész‐Katona, E., Kaci, H., Turu, G., & Hunyady, L. (2026) · Biomolecules · doi:10.3390/biom16020236 · Cited by 4 · see citing works

What is the Impact of Dopamine D2 Receptor in the Brain-Gut Axis? A Narrative Review of the Mechanism Based on Gut Microbiota in Modulating Emotion and Behavior

Xie, Y.-A. N., Kong, J., Li, S. P., & Wei, D.-F. N. (2025) · ALPHA PSYCHIATRY · doi:10.31083/ap39226 · Cited by 3 · see citing works

Oral Administration of Efavirenz Dysregulates the Tph2 Gene in Brain Serotonergic Areas and Alters Weight and Mood in Mice

Rojas-Osornio, S. A., Crespo‐Ramírez, M., Cervantes, V. P., Mata-Marín, A., Martínez-Lara, R., de la Mora, M. P., & Tesoro-Cruz, E. (2024) · Pharmaceuticals · doi:10.3390/ph17060801 · Cited by 3 · see citing works

Neuroinflammation—the role of heteroreceptor complexes

Kiran, N. S., & Rajagopal, S. (2025) · Exploration of Neuroprotective Therapy · doi:10.37349/ent.2025.1004105 · Cited by 1 · see citing works

Neuropeptide signaling and the blood–brain barrier generate a persistent stress-induced internal state in Drosophila

Alia, A. G. M., Hu, X., Gu, Y., Yau, J., Tian, G., Semmelhack, J. L., Saito, K., Tanimoto, H., Tsuyuzaki, K., Naganos, S., et al. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2517987123 · Cited by 1 · see citing works

Preparation and application of boron and fluorine co-doped rGO electrochemical sensor

Jiang, Y., & Wang, G. (2024) · Journal of the Indian Chemical Society · doi:10.1016/j.jics.2024.101310 · Cited by 1 · see citing works

Changes in Targets as an Explanation for Drug Resistance in Epilepsy

Martínez-Aguirre, C., Fonseca‐Barriendos, D., de la Cruz, S. H., Fuentes-Mejía, M., & Rocha, L. L. (2023) · Springer eBooks · doi:10.1007/978-3-031-36526-3_7

Genes Involved in Neuropsychiatric Disorders: A Focus on Tetraspanin Genes

Hajmusa, D., & Bahí, A. (2024) · Springer eBooks · doi:10.1007/978-3-031-32035-4_3-1

Moonlighting proteins in neurobiology signaling mediated by G protein-coupled receptors

Mirchandani‐Duque, M., Choucri, M., Laffita‐Mesa, J. M., Hernández-García, A., Danielson, A., Martínez-Cortés, A., Berrocoso, E., Fuxé, K., & Borroto-Escuela, D. O. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-15719-6.00003-9

Neuropeptide signalling and perineurial barrier generate a persistent stress-induced internal state in DrosophilaPreprint

Alia, A. G. M., Hu, X., Gu, Y., Tian, G., Semmelhack, J. L., Saito, K., Tanimoto, H., Tsuyuzaki, K., Naganos, S., Miyashita, T., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.05.08.652787

Genes Involved in Neuropsychiatric Disorders: A Focus on Tetraspanin Genes

Hajmusa, D., & Bahí, A. (2025) · Springer eBooks · doi:10.1007/978-3-031-73368-0_3

Forest therapy as an intervention for depressive disorders: a review of the mechanisms and applications

Hu, F., Wu, C., & Liu, W. T. (2026) · Frontiers in Public Health · doi:10.3389/fpubh.2026.1760446

Fibroblast growth factor receptor 1: Bridge to understanding mental disorders

Fan, F., Wang, B., Chen, Z.-L., Li, W.-F., & Han, F. (2026) · World Journal of Psychiatry · doi:10.5498/wjp.118781

On the Disbalance and Impairment of Serotonin Heteroreceptor Complexes in the Rat Brain After MDMA and Hallucinogens Administration

Fuxé, K., & Borroto‐Escuela, D. O. (2022) · Springer eBooks · doi:10.1007/978-3-030-71519-9_189-1

Understanding the Role of GPCR Heteroreceptor Complexes in Modulating the Brain Networks in Health and Disease

Borroto‐Escuela, D. O., Carlsson, J., Ambrogini, P., Narváez, M., Wydra, K., Tarakanov, A. O., Li, X., Millón, C., Ferraro, L., Cuppini, R., et al. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00037 · Cited by 375 · see citing works

Serotonin Heteroreceptor Complexes and Their Integration of Signals in Neurons and Astroglia—Relevance for Mental Diseases

Borroto‐Escuela, D. O., Ambrogini, P., Narváez, M., Liberto, V. D., Beggiato, S., Ferraro, L., Fores‐Pons, R., Alvarez‐Contino, J. E., López‐Salas, A., Mudò, G., et al. (2021) · Cells · doi:10.3390/cells10081902 · Cited by 29 · see citing works

σ-1 receptors in major depression and anxiety

Kulkarni, S. K., & Dhir, A. (2009) · Expert Review of Neurotherapeutics · doi:10.1586/ern.09.40 · Cited by 70 · see citing works

G Proteins in the Pathophysiology and Treatment of Mood and Anxiety Disorders

Manji, H. K. (2003) · Humana Press eBooks · doi:10.1385/0-89603-490-9:283